As Cardiovascular Systems INC (CSII) Share Price Rose, Champlain Investment Partners LLC Has Lowered Its Holding by $5.57 Million

October 13, 2018 - By whatsonthorold

Investors sentiment increased to 1.27 in Q2 2018. Its up 0.41, from 0.86 in 2018Q1. It improved, as 10 investors sold CSII shares while 39 reduced holdings. 23 funds opened positions while 39 raised stakes. 27.95 million shares or 6.50% more from 26.24 million shares in 2018Q1 were reported. 406,772 were reported by Deutsche Savings Bank Ag. 13,314 are held by Voya Management Ltd Co. United Kingdom-based Legal And General Grp Public Ltd Co has invested 0% in Cardiovascular Systems, Inc. (NASDAQ:CSII). Nj State Employees Deferred Compensation Plan holds 0.05% or 9,000 shares in its portfolio. Wells Fargo Company Mn reported 48,639 shares. 21,010 were accumulated by Tudor Invest Corporation Et Al. Panagora Asset Inc reported 0% of its portfolio in Cardiovascular Systems, Inc. (NASDAQ:CSII). Sei Invests Communications owns 30 shares or 0% of their US portfolio. D E Shaw And Company stated it has 714,340 shares or 0.03% of all its holdings. Grp One Trading LP stated it has 2,200 shares. Teton Advsr stated it has 111,100 shares or 0.32% of all its holdings. 24,919 are owned by Principal Group. Jane Street Group Ltd Liability Corp reported 10,934 shares. Northern Tru Corp owns 0% invested in Cardiovascular Systems, Inc. (NASDAQ:CSII) for 438,755 shares. Gabelli Funds Ltd Liability reported 0.04% stake.

Champlain Investment Partners Llc decreased its stake in Cardiovascular Systems Inc. (CSII) by 6.72% based on its latest 2018Q2 regulatory filing with the SEC. Champlain Investment Partners Llc sold 174,170 shares as the company’s stock rose 25.60% with the market. The institutional investor held 2.42M shares of the health care company at the end of 2018Q2, valued at $78.14M, down from 2.59 million at the end of the previous reported quarter. Champlain Investment Partners Llc who had been investing in Cardiovascular Systems Inc. for a number of months, seems to be less bullish one the $1.21 billion market cap company. The stock increased 0.61% or $0.21 during the last trading session, reaching $34.77. About 225,178 shares traded. Cardiovascular Systems, Inc. (NASDAQ:CSII) has risen 27.95% since October 13, 2017 and is uptrending. It has outperformed by 12.33% the S&P500.

Champlain Investment Partners Llc, which manages about $6.04B and $10.33B US Long portfolio, upped its stake in Ulta Beauty Inc (NASDAQ:ULTA) by 31,100 shares to 450,375 shares, valued at $105.15M in 2018Q2, according to the filing. It also increased its holding in German American Bancorp Inc. (NASDAQ:GABC) by 136,110 shares in the quarter, for a total of 1.10M shares, and has risen its stake in Simply Good Foods Co.

Analysts await Cardiovascular Systems, Inc. (NASDAQ:CSII) to report earnings on October, 24. They expect $-0.05 EPS, up 16.67 % or $0.01 from last year’s $-0.06 per share. After $0.11 actual EPS reported by Cardiovascular Systems, Inc. for the previous quarter, Wall Street now forecasts -145.45 % negative EPS growth.

Cardiovascular Systems, Inc. (NASDAQ:CSII) Ratings Coverage

Among 2 analysts covering Cardiovascular Systems (NASDAQ:CSII), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cardiovascular Systems had 2 analyst reports since June 27, 2018 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, June 27 by Bank of America.

Cardiovascular Systems, Inc. (NASDAQ:CSII) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>